maltose tetrapalmitate

Antiangiogenesis is an appealing therapeutic modality for the treatment of a number of clinically important diseases, including… Expand

Maltose tetrapalmitate (MTP), a non-toxic synthetic glycolipid analog of lipid A, has been shown to have antitumor activity in… Expand

The antitumor activity of either cortisone-heparin or cortisone-maltose tetrapalmitate combination or both was tested against two… Expand

Pathological studies were undertaken in three tumor-host models which were subjected to cortisone based treatments. The first… Expand

We divided randomly into 3 groups 47 patients with recurrent superficial transitional cell carcinoma of the bladder: group 1-15… Expand

Therapeutic effects of radiotherapy (R), chemotherapy, and maltose tetrapalmitate (MTP) immunotherapy alone and in combinations… Expand

Maltose tetrapalmitate (MTP), a synthetic nontoxic immunoadjuvant, the radiosensitizer misonidazole (MISO), and 60Co gamma… Expand

Chemoimmunotherapy in two animal models for urological cancers was studied. The models were Dunning R3327A prostatic carcinoma… Expand

The prophylactic effect of maltose tetrapalmitate (MTP), a newly developed non specific immunoadjuvant in preventing or delaying… Expand

The effectivenss of maltose tetrapalmitate (MTP) as an antitumour immune adjuvant was verified by its comparison with other known… Expand